Prescribing inhalers offers physicians a chance to impact climate change — but switching to greener options comes with ...

Yupelri (revefenacin) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a liquid solution for inhalation with a jet nebulizer. It’s typically ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

Inhalers generated more than 2 million metric tons of carbon emissions annually over the past decade, researchers reported ...

The situation is an ironic one. While climate change is worsening respiratory illnesses — by increasing extreme heat, spreading smoke from wildfires, and lowering air quality — one of the most common ...

As-needed use of a metered-dose inhaler with albuterol plus budesonide (Airsupra) lowered the risk of severe exacerbations compared with albuterol alone for people with normally mild asthma, the phase ...

Climate change is making asthma worse, as hotter temperatures increase ozone pollution and wildfires and make pollen season longer. But asthma, ironically, is also making climate change worse: ...

Asthma inhalers are critical for delivering small amounts of medication to people's lungs to improve breathing and help ...

As AstraZeneca fights to defend its aging two-drug inhaler Symbicort against generics, the company has a new approval to bolster its respiratory business. Wednesday, the British drugmaker said the FDA ...